ArticleCureus2025

Comparison of One-Year Adverse Events Between First- and Second-Generation Bruton's Tyrosine Kinase Inhibitors: A Retrospective Study.

Ao Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.